1. Home
  2. ATOS vs DAIO Comparison

ATOS vs DAIO Comparison

Compare ATOS & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$2.12

Market Cap

36.2M

Sector

Health Care

ML Signal

HOLD

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$3.79

Market Cap

37.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATOS
DAIO
Founded
2009
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
36.2M
37.9M
IPO Year
2010
1995

Fundamental Metrics

Financial Performance
Metric
ATOS
DAIO
Price
$2.12
$3.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$23.00
$5.22
AVG Volume (30 Days)
300.7K
63.1K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,758.00
$21,500,000.00
Revenue This Year
N/A
$4.51
Revenue Next Year
N/A
$30.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$2.16
52 Week High
$7.56
$4.49

Technical Indicators

Market Signals
Indicator
ATOS
DAIO
Relative Strength Index (RSI) 29.03 52.20
Support Level $0.58 $3.48
Resistance Level $6.18 $4.10
Average True Range (ATR) 0.17 0.23
MACD 0.05 -0.04
Stochastic Oscillator 42.00 36.13

Price Performance

Historical Comparison
ATOS
DAIO

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About DAIO Data I/O Corporation

Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.

Share on Social Networks: